Skip to main content
Livermore
Livermore
ZHEN

Fairmount Funds Management LLC

SEC CIK
0001802528
Latest filing
Aug 14, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Fairmount Funds Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AXSM by Fairmount Funds Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−815,176−100.0%Sold outHolders
Q3 2025815,176$99.0M8.9%00.0%UnchangedHolders
Q2 2025815,176$85.1M11.0%00.0%UnchangedHolders
Q1 2025815,176$95.1M14.7%−653,807−44.5%ReducedHolders
Q4 20241,468,983$124.3M12.4%−891,094−37.8%ReducedHolders
Q3 20242,360,077$212.1M17.2%00.0%UnchangedHolders
Q2 20242,360,077$190.0M21.5%00.0%UnchangedHolders
Q1 20242,360,077$188.3M20.5%00.0%UnchangedHolders
Q4 20232,360,077$187.8M19.8%+18,839+0.8%AddedHolders
Q3 20232,341,238$163.6M19.7%−3,742−0.2%ReducedHolders
Q2 20232,344,980$168.5M23.8%+333,333+16.6%AddedHolders
Q1 20232,011,647$124.1M21.3%00.0%UnchangedHolders
Q4 20222,011,647$155.2M24.6%+115,000+6.1%AddedHolders
Q3 20221,896,647$84.6M15.6%+954,076+101.2%AddedHolders
Q2 2022942,571$36.1M8.3%00.0%UnchangedHolders
Q1 2022942,571$39.0M9.2%+754,973+402.4%AddedHolders
Q4 2021187,598$7.09M2.3%00.0%UnchangedHolders
Q3 2021187,598$6.18M2.2%−125,000−40.0%ReducedHolders
Q2 2021312,598$21.1M8.7%+61,000+24.2%AddedHolders
Q1 2021251,598$14.2M6.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.